tradingkey.logo

Gelteq Ltd

GELS
查看詳細走勢圖
0.806USD
+0.006+0.76%
收盤 02/06, 16:00美東報價延遲15分鐘
8.63M總市值
虧損本益比TTM

Gelteq Ltd

0.806
+0.006+0.76%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.76%

5天

-16.91%

1月

-5.72%

6月

-48.98%

今年開始到現在

+0.76%

1年

-64.80%

查看詳細走勢圖

TradingKey 股票評分

由於缺少必要的數據,暫時無法對該公司進行評分

Gelteq Ltd新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Gelteq Ltd簡介

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
公司代碼GELS
公司Gelteq Ltd
CEOGivoni (Nathan Jacob)
網址https://www.gelteq.com
KeyAI